Page 7 - Alexion Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alexion pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alexion Pharmaceutical Today - Breaking & Trending Today

Saratoga Biochar wants to convert biosolids to fertilizer in Moreau; residents say whoa

Moreau residents oppose Saratoga Biochar s plans ....

Not Moreau , Industrial Park , Gina Leclaire , Not Moreau , Mandy Mahoney , Raymond Apy , Mary Clear , Hudson River , Hudson Falls , Port Edward , Industrial Park , General Electric , Saratoga Biochar , Saratoga Biochar Solutions , Planning Board , Times Union , Us Environmental Protection Agency , Band Aid , Science Direct ,

AstraZeneca's Boston-area expansion poses no threat to CT presence, officials say

AstraZeneca plans to open a new research and development facility in Massachusetts, but. ....

United States , New Haven , United Kingdom , Kendall Square , Paul Pescatello , Ginny Kozlowski , Pascal Soriot , Mike Piscitelli , Development Economic Corp , Connecticut Bioscience Growth Council , College St , Seaport District , Bioscience Growth Council , Economic Development , Pascal Soriot , Paul Pescatello , Ginny Kozlowski , Mike Piscitelli , New Haven , Kendall Square , College Street , Seaport District , 01 College St , Alexion Pharmaceuticals , Connecticut Bioscience Growth Council , Ex Development Economic Corp ,

AstraZeneca's Ultomiris scores its 3rd FDA approval, setting up market clash with argenx

The FDA has approved AstraZeneca's Ultomiris to treat generalized myasthenia gravis, an autoimmune neuromuscular disorder. ....

Ultomiris Ravulizumab Cwvz , Marc Dunoyer , Paroxysmal Nocturnal Hemoglobinuria , Fierce Pharma Homepage ,

AstraZeneca's Alexion to expand in New Haven's new biotech tower

The 10 story-building that is being built at 101 College St. is located directly across. ....

United States , Science Park , New Haven , Yale University , Garrett Sheehan , Mike Piscitelli , Church St , Greater New Haven Chamber , Elm City Bioscience Center , College St , Winchester Works , New Haven Based , Student Program , Ready Interns , Next Generation Talent , Elm City , Nnalise Carol , Garrett Sheehan , Mike Piscitelli , New Haven , 00 College St , 01 College St , Alexion Pharmaceuticals , College Street , 65 Church St , Science Park ,

BioCryst pauses 3 rare disease trials, shares plummet

In just 72 words, BioCryst announced it would pause enrollment for three phase 2 trials of its rare disease candidate BCX9930, sending shares tumbling 30%. ....

Biocryst Pharmaceuticals , Kidney Disease , Paroxysmal Nocturnal Hemoglobinuria , Clinical Trial , Fierce Biotech Homepage ,